Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc. (ORMP) is a pharmaceutical company focused on the development of oral drug delivery systems – most notably, insulin capsules for the treatment of type 2 diabetes.
This is an exciting development for the medical community and anyone required to inject themselves with insulin.
On Friday, the company announced that its majority-owned subsidiary, Oravax Medical, received clearance to begin Phase 1 clinical trials of its oral COVID-19 vaccine in South Africa.
Needless to say, there is plenty of news to keep interest alive and demand high for shares of ORMP.
Here’s how the chart is setting up:
And here’s how the stock is setting up with my Stock Surge Indicator (SSI):
- Surge score: 99/100
- % Above 52-wk low: 850%
- MFI reading: 58
- Sales growth: +0%
- Triple momentum: yes
As a clinical-stage firm, there are no sales or earnings to analyze. But institutional investors appear to be getting interested.
At the end of last year, only 12 funds owned the stock. Last quarter, that number had jumped to 92.
I’m looking to buy ORMP on a move above $23.98. Depending on one’s risk tolerance, you could place a tight stop at $22.70 or give it room and use $21.30.
(If you’re new to Stock Surge Daily or just unsure of how to best take advantage of these weekly trades, be sure to check out my article from last week, How to Follow My Weekly Trades.)
Revolve Group, Inc.
Revolve Group, Inc. (RVLV) is a Cerritos, California-based online fashion retailer that aims to connect consumers and global fashion influencers.
The company’s platform carries trendy luxury brand apparel, shoes and accessories and works with social media influencers to build and promote those brands.
Here’s how the chart is setting up:
And here’s how the stock is setting up with my SSI:
- Surge score: 97/100
- % Above 52-wk low: 296%
- MFI reading: 48
- Sales growth: +60%
- Triple momentum: yes
You may remember this stock from the Oct. 18 Watchlist. Those who followed the trade should be up a little over 4%.
But we haven’t yet seen the large surge that I am still expecting.
In fact, price contracted even further over the last two weeks and set up what I believe is an even better entry.
I have a buy stop order set at $75.15. That is my entry trigger.
Once filled, I will work a sell stop at $69.40.
Century Casinos, Inc.
Century Casinos, Inc. (CNTY), as the name implies, is a worldwide casino entertainment company.
In addition to traditional casinos, the company also develops and operates lodging, restaurant, horse racing and other entertainment facilities like bars, showrooms, event venues and even comedy clubs.
Here’s how the chart is setting up:
And here’s how the stock is setting up with my SSI:
- Surge score: 96/100
- % Above 52-wk low: 216%
- MFI reading: 57
- Sales growth: +155%
- Triple momentum: yes
After climbing more than 14-fold off its COVID-induced lows, CNTY began to consolidate in June. It has formed a robust base with corrections shrinking from 32% down to 6%.
The company has beaten earnings expectations by a wide margin in each of the last five quarters.
It is scheduled to report again on Nov. 5, before the market opens, and I wouldn’t be surprised to see another blowout number.
I will be looking to buy on new highs with a stop below the swing low.
And remember, if you’re unsure of how to best take advantage of these weekly trades, be sure to check out my article from last week, How to Follow My Weekly Trades.
